In the Standards of Medical Care in Diabetes2021, the ADA recommend that for people with indications of high risk or established CKD either a sodium-glucose co-transporter-2 inhibitor (SGLT2i) or a glucagon-like peptide-1 receptor agonist (GLP-1 RA) be considered as a treatment option, independently of metformin use [15]
In research, it increases the production of collagen, elastin, and glycosaminoglycans and supports blood vessel growth
A 90-person Indonesian multicentre trial testing oral glutathione plus vitamin C, alpha-lipoic acid, and zinc over 12 weeks in participants with Fitzpatrick IV and V skin types, a melanin range broadly similar to a lot of Indian skin found the glutathione group trended better on spot and tone measurements, but the difference from placebo didn't reach statistical significance for the group as a whole
Park S, Lim W, Bazer FW, Whang KY, Song G